Skip to search formSkip to main contentSkip to account menu

Mirena

Known as: Berlex Brand of Levonorgestrel, Levonorgestrel Berlex Brand, Schering Brand 1 of Levonorgestrel 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

Levonorgestrellevonorgestrel-releasing intrauterine system
Levonorgestrel 0.000833 MG/HR Intrauterine System [Mirena]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
The benefits and risks of using a levonorgestrel-releasing intrauterine system for contraception.
2012
2012
Relative cost effectiveness of Depo-Provera®, Implanon®, and Mirena® in reversible long-term hormonal contraception in the UK
AbstractObjective: To estimate the relative cost effectiveness for women aged ≥30 years, starting long-term hormonal… 
Review
2012
Review
2012
Ultrasound-guided hysteroscopy to remove a levonorgestrel intrauterine system in early pregnancy.
Review
2011
Review
2011
General practitioners' views on the use of the levonorgestrel-releasing intrauterine system in young, nulligravid women, in London, UK
ABSTRACT Background and objectives The levonorgestrel-releasing intrauterine system (LNG-IUS, Mirena®) is one of the most… 
2010
2010
Prognostic significance of estrogen and progesterone receptor expression in LNG‐IUS (Mirena®) treatment of endometrial hyperplasia: an immunohistochemical study
We performed immunohistochemical analysis of estrogen (ERα) and progesterone receptors (PRA and PRB), phosphatase and tensin… 
2009
2009
Do users of the intrauterine system (Mirena) have different genital symptoms and vaginal flora than users of the intrauterine contraceptive device?
The copper intrauterine contraceptive device (IUCD) is strongly associated with bacterial vaginosis (BV). Hormonal influences may… 
Review
2007
Review
2007
Retained hormone release capsule following removal of Mirena intrauterine system
We wish to report a case of secondary amenorrhoea caused by the unrecognised retention in the uterine cavity of the active part… 
2003
2003
Insertion of intrauterine devices: a comparison of experience with Mirena and Multiload Cu 375 during post-marketing monitoring in New Zealand.
AIM To compare the incidence of reported insertion problems with the levonorgestrel-releasing intrauterine device (Mirena) with… 
Review
2002
Review
2002
Providing pharmaceutical care to the multiple sclerosis patient.
OBJECTIVE To review the pathophysiology, symptoms, and treatment of multiple sclerosis (MS). DATA SOURCES Recently published… 
1999
1999
[Sonographic demonstration of a levonorgestrel-releasing IUD (Mirena)].
Mirena, a new intra-uterine device (IUD) introduced in Israel during the past year, releases 20 mcg/day of levonorgestrel for 5… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)